Peptonic appoints Albert Lindgren as CFO
Peptonic Medical AB (publ) today announces that Albert Lindgren has been appointed Chief Financial Officer (CFO) and member of Group Management. He will take up his position on October 21 2023.
In connection with the recruitment of Albert Lindgren, the CFO role is established as a new full time position in Peptonic. Albert Lindgren will report to CEO Erik Sundquist.
"Albert has a solid background from working with finance issues in an international environment in an expansive phase. These are valuable experiences for us now given our growth plans for the coming years. Peptonic is in an exciting phase where we see a great interest in our products in clinically proven intimate self-care from several leading international distributors", says Erik Sundquist, CEO of Peptonic.
"Through the acquisition of Pharmiva, which is planned to be completed during the second half of this year, we become both a larger and stronger company and further improve our conditions. We look forward to welcoming Albert to Peptonic", he continues.
Albert Lindgren most recently comes from Viaplay where he has held various leading roles within the finance function since 2016, including VP Head of Finance Commercial and most recently as VP Finance Continental Europe. He also has experience from Deloitte as a consultant in Business Process Solutions during 2015–2016. Albert holds a bachelor's degree in economics from Lund University and a master's degree in Economics & Business Administration from Copenhagen Business School.
Erik Sundquist, CEO
Telefon: + 46 722 49 90 43
E-post: erik.sundquist@peptonicmedical.se
About PEPTONIC medical AB
Peptonic is a Swedish innovative biomedical company that conducts research, development and sales of medical treatments and lifestyle products in the field of women's health. Peptonic has divided its operations into two business areas: "Medical Consumer" and "Lifestyle Consumer". The "Medical Consumer" business area is based on clinically proven intimate self-care and is the company's main focus and is sold under the VagiVital brand. The "Lifestyle Consumer" business area consists of lifestyle products with a focus on menstruation, sex and fertility and is sold under the Lunette brand. The company was founded in 2009 and the share has been traded on Spotlight (www.spotlightstockmarket.com) in Stockholm since 2014.